中国癌症杂志
中國癌癥雜誌
중국암증잡지
CHINA ONCOLOGY
2009年
10期
779-783
,共5页
顾红军%武宁%胡海洋%宋晓莲%董宇超%李强
顧紅軍%武寧%鬍海洋%宋曉蓮%董宇超%李彊
고홍군%무저%호해양%송효련%동우초%리강
组蛋白去乙酰化酶%肺肿瘤%曲古霉素A%凋亡
組蛋白去乙酰化酶%肺腫瘤%麯古黴素A%凋亡
조단백거을선화매%폐종류%곡고매소A%조망
histone deacetylases%lung neoplasms%trichostatin A%apoptosis
背景与目的:曲古霉素A(trichostatin A,TSA)是具有组蛋白去乙酰化酶(histonedeacetylases,HDAC)强效非竞争性抑制剂,对血液系统肿瘤和实质性肿瘤均有较强的生长抑制作用.本文观察HDACs抑制剂TSA对体外培养的肺腺癌NCI-H1299细胞株的增殖、凋亡和周期以及相关基因表达的影响,并探讨其可能的作用机制.方法:MTT法检测不同浓度(0.1、0.2、0.4、2.0 μmol/L)的TSA对人肺腺癌NCI-H1299细胞株体外增殖的影响,流式细胞术检测药物处理后细胞周期及凋亡率的变化;Western blot法检测细胞内组蛋白H4乙酰化水平的变化:Real-time PCR检测NCI-H1299细胞内p21、CyclinBl、Bcl-2和Bax的基因表达.结果:TSA能明显抑制NCI-H1299细胞的体外生长,其抑制作用呈明显的剂量和时间依赖性.TSA诱导后,流式细胞术检测结果显示细胞阻滞于G_2/M期,细胞凋亡增加.TSA可明显提高NCI-H1299细胞内组蛋白H4的乙酰化水平,诱导p21和Bax的mRNA表达增加,同时抑制Bcl-2和CyclinBl表达.结论:TSA可通过诱导细胞凋亡及阻滞细胞周期而发挥体外抗肺腺癌细胞生长的作用,其机制可能与组蛋白乙酰化水平的提高以及调控相关基因p21、Bar、Bcl-2和CyclinBl的表达变化有关.
揹景與目的:麯古黴素A(trichostatin A,TSA)是具有組蛋白去乙酰化酶(histonedeacetylases,HDAC)彊效非競爭性抑製劑,對血液繫統腫瘤和實質性腫瘤均有較彊的生長抑製作用.本文觀察HDACs抑製劑TSA對體外培養的肺腺癌NCI-H1299細胞株的增殖、凋亡和週期以及相關基因錶達的影響,併探討其可能的作用機製.方法:MTT法檢測不同濃度(0.1、0.2、0.4、2.0 μmol/L)的TSA對人肺腺癌NCI-H1299細胞株體外增殖的影響,流式細胞術檢測藥物處理後細胞週期及凋亡率的變化;Western blot法檢測細胞內組蛋白H4乙酰化水平的變化:Real-time PCR檢測NCI-H1299細胞內p21、CyclinBl、Bcl-2和Bax的基因錶達.結果:TSA能明顯抑製NCI-H1299細胞的體外生長,其抑製作用呈明顯的劑量和時間依賴性.TSA誘導後,流式細胞術檢測結果顯示細胞阻滯于G_2/M期,細胞凋亡增加.TSA可明顯提高NCI-H1299細胞內組蛋白H4的乙酰化水平,誘導p21和Bax的mRNA錶達增加,同時抑製Bcl-2和CyclinBl錶達.結論:TSA可通過誘導細胞凋亡及阻滯細胞週期而髮揮體外抗肺腺癌細胞生長的作用,其機製可能與組蛋白乙酰化水平的提高以及調控相關基因p21、Bar、Bcl-2和CyclinBl的錶達變化有關.
배경여목적:곡고매소A(trichostatin A,TSA)시구유조단백거을선화매(histonedeacetylases,HDAC)강효비경쟁성억제제,대혈액계통종류화실질성종류균유교강적생장억제작용.본문관찰HDACs억제제TSA대체외배양적폐선암NCI-H1299세포주적증식、조망화주기이급상관기인표체적영향,병탐토기가능적작용궤제.방법:MTT법검측불동농도(0.1、0.2、0.4、2.0 μmol/L)적TSA대인폐선암NCI-H1299세포주체외증식적영향,류식세포술검측약물처리후세포주기급조망솔적변화;Western blot법검측세포내조단백H4을선화수평적변화:Real-time PCR검측NCI-H1299세포내p21、CyclinBl、Bcl-2화Bax적기인표체.결과:TSA능명현억제NCI-H1299세포적체외생장,기억제작용정명현적제량화시간의뢰성.TSA유도후,류식세포술검측결과현시세포조체우G_2/M기,세포조망증가.TSA가명현제고NCI-H1299세포내조단백H4적을선화수평,유도p21화Bax적mRNA표체증가,동시억제Bcl-2화CyclinBl표체.결론:TSA가통과유도세포조망급조체세포주기이발휘체외항폐선암세포생장적작용,기궤제가능여조단백을선화수평적제고이급조공상관기인p21、Bar、Bcl-2화CyclinBl적표체변화유관.
Background and purpose: Trichostatin A (TSA), an antifungal antibiotic with cytostatic and differentiating properties in mammalian cell culture, is a potent and specific inhibitor of histone deacetylase (HDAC). This study was aimed to investigate the influence of trichostatin A on the growth of human lung adenocacinoma cells in vitro, and to explore the mechanisms involved. Methods: MTT assay was employed to evaluate the inhibitory effect of TSA (0.1, 0.2,0.4 μmol/L) on the growth of human NCI-H1299 cancer cells. The cell cycle distribution and apoptotic ratio were determined by flow cytometry. The acetyl level of histone H4 after TSA treatment was detected by Western blot;the mRNA level of Bax,Bcl-2,p21 and cyelinBl was measured by Real-time PCR. Results: TSA inhibited the growth of NCI-H1299 cells in a dose-and time-dependent manner. Flow cytometry showed that the cells were blocked at G_2/M phase and cell apoptosis was increased compared to the control. TSA significantly increased the acetyl level of histone H4, induced p21 and Bax expression, and inhibited the expression of cyclin BI and Bcl-2. Conclusion: TSA inhibits the growth of lung cancer cells in vitro through inducing cell apoptosis and cell cycle arrest, which might be related to its regulatory effects on the acetyl blot of histone and the expression of p21, Bax, Bcl-2 and cyclinBl.